메뉴 건너뛰기




Volumn 23, Issue 10, 2008, Pages 3280-3282

Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis

Author keywords

Gadodiamide; Gadolinium

Indexed keywords

GADOLINIUM; SODIUM THIOSULFATE;

EID: 52449094150     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn217     Document Type: Article
Times cited : (22)

References (6)
  • 1
    • 0034675322 scopus 로고    scopus 로고
    • Scleromyxoedema-like cutaneous diseases in renal-dialysis patients
    • Cowper SE, Robin HS, Steinberg SM et al. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000; 356: 1000-1001
    • (2000) Lancet , vol.356 , pp. 1000-1001
    • Cowper, S.E.1    Robin, H.S.2    Steinberg, S.M.3
  • 2
    • 40449106988 scopus 로고    scopus 로고
    • Clinical manifestations of gadodiamide-related nephrogenic systemic fibrosis
    • Marckmann P, Skov L, Rossen K, Thomsen HS. Clinical manifestations of gadodiamide-related nephrogenic systemic fibrosis. Clin Nephrol 2008; 69: 161-168
    • (2008) Clin Nephrol , vol.69 , pp. 161-168
    • Marckmann, P.1    Skov, L.2    Rossen, K.3    Thomsen, H.S.4
  • 3
    • 33748049106 scopus 로고    scopus 로고
    • Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging
    • Marckmann P, Skov L, Rossen K et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006; 17: 2359-2362
    • (2006) J Am Soc Nephrol , vol.17 , pp. 2359-2362
    • Marckmann, P.1    Skov, L.2    Rossen, K.3
  • 4
    • 35348892608 scopus 로고    scopus 로고
    • Nephrogenic systemic fibrosis (NSF): A late adverse reaction to some of the gadolinium based contrast agents
    • Thomsen HS, Marckmann P, Logager VB. Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents. Cancer Imaging 2007; 7: 130-137
    • (2007) Cancer Imaging , vol.7 , pp. 130-137
    • Thomsen, H.S.1    Marckmann, P.2    Logager, V.B.3
  • 5
    • 34249818373 scopus 로고    scopus 로고
    • Nephrogenic systemic fibrosis: A mysterious disease in patients with renal failure-role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate
    • Yerram P, Saab G, Karuparthi PR et al. Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure-role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clin J Am Soc Nephrol 2007; 2: 258-263
    • (2007) Clin J Am Soc Nephrol , vol.2 , pp. 258-263
    • Yerram, P.1    Saab, G.2    Karuparthi, P.R.3
  • 6
    • 38349103948 scopus 로고    scopus 로고
    • Dermal inorganic gadolinium concentrations: Evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis
    • Abraham JL, Thakral C, Skov L et al. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis. Br J Dermatol 2008; 158: 273-280
    • (2008) Br J Dermatol , vol.158 , pp. 273-280
    • Abraham, J.L.1    Thakral, C.2    Skov, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.